Patent Foramen Ovale (PFO)Learn More
Artrial Septal Defect (ASD)Learn More
Ventricular Septal Defect (VSD)Learn More
NMT Medical is a pioneer in the field of non-surgical repair of structural heart defects in children and adults. Over 27,000 septal defects have been closed using our proprietary technology.
Recently Completed Trials:MIST (Migraine Intervention with STARFlex® Technology) defined the “treatment effect” of closing a patent foramen ovale (PFO) in certain patients suffering from refractory migraine headache.
BEST (BioSTAR® Evaluation Study) demonstrated closure rates for the worlds first bioabsorbable septal repair implant to be significantly better than competing technologies.
Ongoing Clinical trials:CLOSURE I - compares current medical therapy to PFO closure in patients who have experienced a stroke or TIA.
MIST III - is a follow-on study to the completed MIST trial.
5/5/2008 NMT Medical Announces First-Quarter 2008 Financial Results
4/10/2008 NMT Medical to Release First-Quarter 2008 Financial Results on May 6
3/4/2008 NMT Medical Announces Fourth-Quarter and Year-End 2007 Results
3/3/2008 NMT Medical to Present at Cowen and Company's 28th Annual Health Care Conference
2/1/2008 NMT Medical to Release Fourth-Quarter and Year-End 2007 Financial Results on March 5